Gene structure and transcriptional regulation of human gal β1,4(3) GlcNAc α2,3-sialyltransferase VI (hST3Gal VI) gene in prostate cancer cell line

被引:25
作者
Taniguchi, A [1 ]
Kaneta, R [1 ]
Morishita, K [1 ]
Matsumoto, K [1 ]
机构
[1] Toho Univ, Sch Pharmaceut Sci, Dept Clin Chem, Funabashi, Chiba 2748510, Japan
关键词
luciferase assay; gene regulation; sialic acid; dual promoter; multiple mRNA isoforms;
D O I
10.1006/bbrc.2001.5709
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We describe transcriptional regulation of the human Gal beta1,4(3) GlcNAc alpha2,3-sialyltransferase VI (hST3Gal VI) gene. The 5'-RACE results indicated that two mRNA forms differ only in the 5'-untranslated region (types 1 and 2). The genomic structure shows that the transcriptional regulation of type 1 and type 2 mRNA depends on the P1 and P2 promoters, respectively. Northern blots of RNA derived from various human tissues showed that the expression level of type 2 mRNA is higher than that of type I in the prostate. To elucidate the molecular basis of hST3Gal VI gene ex. pression, we isolated and functionally characterized the genomic region containing the P1 and P2 promoters of hST3Gal VI. The activity of the P2 promoter is much higher than that of the P1 promoter in the prostate adenocarcinoma cell line PC-3. The results suggested that the hST3Gal VI gene is expressed specifically by alternative promoter utilization and is regulated in a tissue-restricted fashion at the level of transcription. (C) 2001 Academic Press.
引用
收藏
页码:1148 / 1156
页数:9
相关论文
共 43 条
[1]   CHARACTERIZATION OF A PROMOTER REGION SUPPORTING TRANSCRIPTION OF A NOVEL HUMAN BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE TRANSCRIPT IN HEPG2 CELLS [J].
AASENG, DA ;
ASHEIM, HC ;
DEGGERDAL, A ;
SMELAND, E ;
FUNDERUD, S .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1995, 1261 (01) :166-169
[2]   CELL-SPECIFIC EXPRESSION OF HUMAN BETA-GALACTOSIDE ALPHA-2,6-SIALYTRANSFERASE TRANSCRIPTS DIFFERING IN THE 5' UNTRANSLATED REGION [J].
AASHEIM, HC ;
AASENG, DA ;
DEGGERDAL, A ;
BLOMHOFF, HK ;
FUNDERUD, S ;
SMELAND, EB .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 213 (01) :467-475
[3]   Characterization of terminal sialic acid linkages on human thymocytes - Correlation between lectin-binding phenotype and sialyltransferase expression [J].
Baum, LG ;
Derbin, K ;
Perillo, NL ;
Wu, T ;
Pang, M ;
Uittenbogaart, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (18) :10793-10799
[4]   3 GENES THAT ENCODE HUMAN BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASES - STRUCTURAL-ANALYSIS AND CHROMOSOMAL MAPPING STUDIES [J].
CHANG, ML ;
EDDY, RL ;
SHOWS, TB ;
LAU, JTY .
GLYCOBIOLOGY, 1995, 5 (03) :319-325
[5]   Differentiation-dependent expression of human beta-galactoside alpha 2,6-sialyltransferase mRNA in colon carcinoma CaCo-2 cells [J].
DallOlio, F ;
Malagolini, N ;
Guerrini, S ;
Lau, JTY ;
SerafiniCessi, F .
GLYCOCONJUGATE JOURNAL, 1996, 13 (01) :115-121
[6]   HUMAN COLON-CANCER CELL-LINES PERMANENTLY EXPRESSING ALPHA-2,6-SIALYLATED SUGAR CHAINS BY TRANSFECTION WITH RAT BETA-GALACTOSIDE ALPHA-2,6 SIALYLTRANSFERASE CDNA [J].
DALLOLIO, F ;
CHIRICOLO, M ;
LOLLINI, P ;
LAU, JTY .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 211 (02) :554-561
[7]   Tissue-specific and androgen-regulated expression of human prostate-specific transglutaminase [J].
Dubbink, HJ ;
Verkaik, NS ;
Faber, PW ;
Trapman, J ;
Schroder, FH ;
Romijn, JC .
BIOCHEMICAL JOURNAL, 1996, 315 :901-908
[8]   Differential gene expression of a human α2,3-sialyltransferase in leukaemic cell lines and leucocytes [J].
Gassen, U ;
Kelm, S ;
Schauer, R .
FEBS LETTERS, 1998, 427 (01) :91-95
[9]   Immune regulation by the ST6Gal sialyltransferase [J].
Hennet, T ;
Chui, D ;
Paulson, JC ;
Marth, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) :4504-4509
[10]   ANDROGENS UP-REGULATE THE HUMAN PROSTATE-SPECIFIC ANTIGEN MESSENGER-RIBONUCLEIC-ACID (MESSENGER-RNA), BUT DOWN-REGULATE THE PROSTATIC ACID-PHOSPHATASE MESSENGER-RNA IN THE LNCAP CELL-LINE [J].
HENTTU, P ;
LIAO, SS ;
VIHKO, P .
ENDOCRINOLOGY, 1992, 130 (02) :766-772